Punjab is a rapidly emerging state in the field of pharmaceuticals. Here, with the support of the central government, a bulk drug pharma park is being developed in Bathinda on 1,300 acres of land at a cost of ₹1,
Mr. Adak has earned a reputation as a visionary leader, constantly pushing the boundaries of what is possible in the API industry.
Takeda Pharmaceutical’s high dividend yield reveals risks from exchange rates, high debt, and patent expirations impacting revenue stability. Read more here.
Shares of Sun Pharmaceutical Industries Ltd. 524715 inched up 0.53% to 1,809.65 Indian rupees Thursday, on what proved to be an all-around great trading session for the stock market, with the BSE SENSEX Index 1 rising 1.
Just a few months after Eli Lilly’s tirzepatide (Zepbound) was approved to treat obesity, the pharmaceutical company in January 2024 launched LillyDirect, a digital health platform for patients with obesity,
GCC Pharmaceutical market To Witness 50% Absolute Growth During 2024 To 2030 Says Kuick ResearchDelhi, Dec. 05, 2024 (GLOBE NEWSWIRE) — GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook
LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America, announced a strategic partnership with Clariant, a global leader in specialty chemical manufacturing.
Cost Plus Drugs CEO Alex Oshmyansky TK on the latest episode of the “Rapid Response” podcast.
The recent review of some of the major projects in this industry sector demonstrates the positive impact of strategic projects
Some of the world’s largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the prospects for pharmaceutical stocks after big share swings in the sector, eight sources told Reuters.